Related Experiment Videos
Surgery in ovarian cancer
1Section of Gynecologic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
European Journal of Gynaecological Oncology
|July 12, 2001
Summary
This review examines surgical management for ovarian cancer, including primary and recurrent cases. It summarizes data on cytoreduction and discusses the roles of second-look surgery and palliative surgical interventions.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
Background:
- Ovarian cancer management often involves complex surgical decisions.
- Understanding the efficacy of surgical interventions is crucial for patient outcomes.
Purpose of the Study:
- To review the established role of surgery in treating primary and recurrent ovarian cancer.
- To summarize evidence supporting cytoreductive surgical strategies.
- To discuss the utility of second-look surgery and palliative surgical options.
Main Methods:
- Literature review of surgical management in ovarian cancer.
- Summary of data supporting primary cytoreduction (debulking).
- Summary of data supporting secondary cytoreduction (interval debulking).
Main Results:
- Surgical cytoreduction is a cornerstone in ovarian cancer treatment.
- Complete tumor removal (R0 resection) is associated with improved survival.
- Second-look surgery and palliative procedures have specific indications.
Conclusions:
- Surgical expertise is vital for optimizing ovarian cancer treatment.
- Cytoreductive surgery significantly impacts prognosis in ovarian cancer.
- Careful patient selection is necessary for palliative surgery.